Nochumson, S
Patients seeking tirzepatide specifically for type 2 diabetes management should discuss Mounjaro with their healthcare provider, as it carries the appropriate FDA indication
VANNIER, L
Adrian, S., Scherzinger, A., Sanyal, A., Lake, J.E., Falutz, J., Dub, M.P., Stanley, T.L., Grinspoon, S.K., Mamputu, J., Marsolais, C., Brown, T.T., & Erlandson, K.M
If you experience constant, intense hunger despite being on a therapeutic dose for approximately 12 weeks, with minimal weight loss (less than 5% of body weight), this suggests the medication may not be optimally effective for you
Recent reviews suggest GLP-1 receptor agonists may support ovulatory frequency in some women by addressing underlying metabolic dysfunction, though larger long-term fertility trials are still needed